Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008

WALTHAM, Mass., Dec. 4 Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that Jon Russell, Vice President, Finance, will attend the upcoming RBC Capital Markets 2008 Healthcare Conference being held December 10-11, 2008 at the Westin Times Square Hotel in New York. Mr. Russell's presentation is scheduled for Thursday, December 11, 2008 at 9:00 a.m. and will be made available to the public through a webcast accessible through the Company's website at http://www.invmed.com/investors.cfm and through RBC Capital Markets' website at http://www.wsw.com/webcast/rbc95/panel21/. A replay of the webcast will be available via the links above for 30 days. During his presentation, Mr. Russell may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

For more information about Inverness Medical Innovations, please visit our website at www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

SOURCE Inverness Medical Innovations, Inc.

Latest Press Release on General News

Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis

The Danaher Beacon for Brain Injury Diagnostics seeks to identify mild Traumatic Brain Injury (TBI) earlier and more precisely. Scientists will evaluate new blood-based biomarkers usi...

Philips Shareholders Approve all Proposals at the AGM 2024

May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shar...

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...